Scholars Central

Mini reviewPublished 31 Oct 2022

Nerve Growth Factor and Alzheimers Disease

Authors: Medhane G Cumbay

Department of Pharmacology, Butler University, USA

Clinical Pharmacology & Biopharmaceutics

Volume 11 · Issue 10 · Pages 1–2

Ask about this article

Abstract

Select any words in the title or abstract, or press this and choose a sentence.

Whim-whams growth factor (NGF) is a well- characterized protein that exerts pharmacological goods on a group of cholinergic neurons known to atrophy in Alzheimer's complaint (announcement). Considerable substantiation from beast studies suggests that NGF may be useful in reversing, halting, or at least decelerating the progression of announcement- related cholinergic rudimentary forebrain atrophy, maybe indeed cheapening the cognitive deficiency associated with the complaint.

Ask about this article

Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.

Try:

More from this journal

The newest in Clinical Pharmacology & Biopharmaceutics.

All its articles

Conferences in this field

Upcoming conferences in this field.

Follow

New articles from what you follow go into your email digest, once you agree to alert emails.

  • JournalClinical Pharmacology & Biopharmaceutics
  • SubjectPharmaceutical Sciences
  • BylineArticles whose byline prints “Medhane G Cumbay”

For authors and organisers

Publish, present and keep up with your field

Find the right journal for your paper and submit your manuscript.

Photo: Pexels